Skip to main content
. 2024 Jul 30;14(8):5721–5736. doi: 10.21037/qims-24-457

Table 1. Clinical features of the study population and basic characteristics of the thyroid nodules.

Parameter Benign nodules (n) Malignant nodules (n) P value
No. of patients 198 247
No. of nodules 205 262
Age (years), mean ± SD 48±13 45±13 0.005
Sex, n (%) 0.072
   Male 43 (21.0) 74 (28.2)
   Female 162 (79.0) 188 (71.8)
Nodule size, n (%) 0.002
   Size ≤1 cm 69 (33.7) 79 (30.2)
   Size >1 and ≤4 cm 109 (53.2) 170 (64.9)
   Size >4 cm 27 (13.2) 13 (5.0)
Echogenicity on US, n (%) <0.001
   Hyper/isoechoic 81 (39.5) 12 (4.6)
   Hypoechoic 121 (59.0) 247 (94.3)
   Highly hypoechoic 3 (1.5) 3 (1.1)
Shape on US, n (%) <0.001
   Wider than taller 166 (81.0) 128 (48.9)
   Taller than wide 39 (19.0) 134 (51.1)
Margin on US, n (%) <0.001
   Smooth or ill-defined 194 (94.6) 170 (64.9)
   Irregular or lobulated 11 (5.4) 92 (35.1)
Echogenic foci on US, n (%) <0.001
   No calcification 132 (64.4) 38 (14.5)
   Macrocalcification 38 (18.5) 26 (9.9)
   Rim calcification 3 (1.5) 3 (1.1)
   Punctate echogenic 32 (15.6) 195 (74.5)
Extrathyroidal extension on US, n (%) <0.001
   Absent 202 (98.5) 198 (75.6)
   Present 3 (1.5) 64 (24.4)
Enhancement direction on CEUS, n (%) <0.001
   Scattered 44 (21.5) 14 (5.3)
   Centripetal/centrifugal 161 (78.5) 248 (94.7)
Peak intensity on CEUS, n (%) <0.001
   No/isoenhancement 115 (56.1) 18 (6.9)
   Hypoenhancement 54 (26.3) 224 (85.5)
   Hyperenhancement 36 (17.6) 20 (7.6)
Ring enhancement on CEUS, n (%) <0.001
   Absent 118 (57.6) 246 (93.9)
   Present 87 (42.4) 16 (6.1)
Composition on CEUS, n (%) <0.001
   Nonsolid 20 (9.8) 3 (1.1)
   Solid 185 (90.2) 259 (98.9)

SD, standard deviation; US, ultrasound; CEUS, contrast-enhanced ultrasound.